anmelden
25 € WM-Startbonus auf dein Cash-Konto
OMX Nordic 40
2.663,51
PKT
-29,19
PKT
-1,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.04.23 | Volvo (B) Buy | Deutsche Bank AG | |
| 13.04.23 | Novo Nordisk Outperform | Credit Suisse Group | |
| 12.04.23 | AstraZeneca Overweight | Barclays Capital | |
| 12.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 12.04.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 12.04.23 | Volvo (B) Sell | UBS AG | |
| 12.04.23 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 12.04.23 | Volvo (B) Hold | Jefferies & Company Inc. | |
| 11.04.23 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 11.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.04.23 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 06.04.23 | Kone Equal Weight | Barclays Capital | |
| 05.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 04.04.23 | Volvo (B) Buy | Deutsche Bank AG | |
| 03.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 03.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.04.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 03.04.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 03.04.23 | Hennes Mauritz (H M, H&M) Neutral | Credit Suisse Group | |
| 31.03.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 30.03.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 29.03.23 | Nokia Equal Weight | Barclays Capital | |
| 28.03.23 | Kone Sector Perform | RBC Capital Markets | |
| 25.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.03.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 23.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.03.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 21.03.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets |